Skip Navigation
NIAID > About NIAID > Organization > Division of Microbiology and Infectious Diseases > Indo-US Vaccine Action Program

Division of Microbiology and Infectious Diseases (DMID)

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • Pin it
  • submit to Google +

Health Officials Renew Indo-U.S. Vaccine Action Program

From left) Dr. S Natesh, Adviser Scientist, Indian Department of Biotechnology; NIH Director, Dr. Elias A. Zerhouni; NIAID Director, Dr. Anthony S. Fauci; Fogarty International Center Director, Dr. Roger I. Glass; Secretary of the Indian Department of Biotechnology, Dr. Maharaj K. Bhan; and Science and Technology Counselor from the Embassy of India, Dr. Kamal Kant Dwivedi.

On May 3, 200, NIH and Indian officials signed a Joint Statement to renew the successful 20-year-old Indo-U.S. Vaccine Action program for another five years. (Standing from left) Dr. S Natesh, Adviser Scientist, Indian Department of Biotechnology; National Institutes of Health Director, Dr. Elias A. Zerhouni; National Institute of Allergy and Infectious Diseases Director, Dr. Anthony S. Fauci; Fogarty International Center Director, Dr. Roger I. Glass; Secretary of the Indian Department of Biotechnology, Dr. Maharaj K. Bhan; and Science and Technology Counselor from the Embassy of India, Dr. Kamal Kant Dwivedi.
Credit:  Courtesy of Fogarty International Center

Last Updated May 13, 2007